{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:45Z","timestamp":1772119245915,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00431-017-3077-7","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T02:34:14Z","timestamp":1514514854000},"page":"311-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Is eculizumab efficacious in Shigatoxin-associated hemolytic uremic syndrome? A narrative review of current evidence"],"prefix":"10.1007","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5576-169X","authenticated-orcid":false,"given":"Werner","family":"Keenswijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Raes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Vande Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"3077_CR1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcimb.2012.00090","volume":"2","author":"Y Nguyen","year":"2012","unstructured":"Nguyen Y, Sperandio V (2012) Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol 2:90","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"3077_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. JASN 16(4):1035\u20131050. https:\/\/doi.org\/10.1681\/ASN.2004100861","journal-title":"JASN"},{"issue":"10","key":"3077_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23(10):1749\u20131760. https:\/\/doi.org\/10.1007\/s00467-008-0935-6","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"3077_CR4","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2215\/CJN.08921209","volume":"5","author":"S Nathanson","year":"2010","unstructured":"Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Pi\u00e8trement C, Champion G, Ulinski T, Desch\u00eanes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5(7):1218\u20131228. https:\/\/doi.org\/10.2215\/CJN.08921209","journal-title":"Clin J Am Soc Nephrol"},{"key":"3077_CR5","doi-asserted-by":"crossref","unstructured":"Nester CM, Thomas CP (2012) Atypical hemolytic uremic syndrome: what is it, how is it diagnosed and how is it treated? Hematol Am Soc Hematol Educ Program:617\u2013612","DOI":"10.1182\/asheducation.V2012.1.617.3798924"},{"issue":"26","key":"3077_CR6","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","volume":"364","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F (2011) Eculizumab in severe Shiga-toxin associated HUS N. Engl J Med 364(26):2561\u20132563","journal-title":"Engl J Med"},{"key":"3077_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/DDDT.S25757","volume":"6","author":"LS Keir","year":"2012","unstructured":"Keir LS, Marks SD, Kim JJ (2012) Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther 6:195\u2013208. https:\/\/doi.org\/10.2147\/DDDT.S25757","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3077_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/adc.78.2.190","volume":"78","author":"CM Taylor","year":"1998","unstructured":"Taylor CM, Monnens LA (1998) Advances in haemolytic uraemic syndrome. Arch Dis Child 78(2):190\u2013193. https:\/\/doi.org\/10.1136\/adc.78.2.190","journal-title":"Arch Dis Child"},{"issue":"10 Suppl 17","key":"3077_CR9","first-page":"1","volume":"10","author":"J Laurence","year":"2012","unstructured":"Laurence J (2012) Atypical hemolytic uremic syndrome (aHUS): making the diagnosis. Clin Adv Hematol Oncol 10(10 Suppl 17):1\u201312","journal-title":"Clin Adv Hematol Oncol"},{"issue":"18","key":"3077_CR10","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1182\/blood-2015-03-569277","volume":"126","author":"EM Conway","year":"2015","unstructured":"Conway EM (2015) HUS and the case for complement. Blood 126(18):2085\u20132090. https:\/\/doi.org\/10.1182\/blood-2015-03-569277","journal-title":"Blood"},{"issue":"20","key":"3077_CR11","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"AL St\u00e5hl","year":"2011","unstructured":"St\u00e5hl AL, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117(20):5503\u20135513. https:\/\/doi.org\/10.1182\/blood-2010-09-309161","journal-title":"Blood"},{"issue":"1","key":"3077_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187(1):172\u2013180. https:\/\/doi.org\/10.4049\/jimmunol.1100491","journal-title":"J Immunol"},{"issue":"6","key":"3077_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","volume":"120","author":"TA Fuchs","year":"2012","unstructured":"Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, L\u00e4mmle B (2012) Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 120(6):1157\u20131164. https:\/\/doi.org\/10.1182\/blood-2012-02-412197","journal-title":"Blood"},{"issue":"12","key":"3077_CR14","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2215\/CJN.02730409","volume":"4","author":"JM Thurman","year":"2009","unstructured":"Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C, Christen E, Trachtman H (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4(12):1920\u20131924. https:\/\/doi.org\/10.2215\/CJN.02730409","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"3077_CR15","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1515\/cclm-2015-0024.","volume":"53","author":"M Franchini","year":"2015","unstructured":"Franchini M (2015) Atypical hemolytic uremic syndrome: from diagnosis to treatment. Clin Chem Lab Med 53(11):1679\u20131688. https:\/\/doi.org\/10.1515\/cclm-2015-0024.","journal-title":"Clin Chem Lab Med"},{"key":"3077_CR16","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenm\u00fcller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, M\u00fcnte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Sch\u00f6cklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellh\u00f6ner P, Wiesner M, Zeissig S, B\u00fcning J, Schiffer M, Kuehbacher T, EHEC-HUS consortium (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565","journal-title":"BMJ"},{"key":"3077_CR17","doi-asserted-by":"crossref","first-page":"753e9","DOI":"10.1093\/cid\/cis531","volume":"55","author":"S Loos","year":"2012","unstructured":"Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, H\u00e4rtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, M\u00fcller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, K\u00f6nig J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ (2012) An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 55:753e9","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3077_CR18","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00467-014-2803-x","volume":"29","author":"A Bauer","year":"2014","unstructured":"Bauer A, Loos S, Wehrmann C, Horstmann D, Donnerstag F, Lemke J, Hillebrand G, L\u00f6bel U, Pape L, Haffner D, Bindt C, Ahlenstiel T, Melk A, Lehnhardt A, Kemper MJ, Oh J, Hartmann H (2014) Neurologial involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol 29(9):1607\u20131615. https:\/\/doi.org\/10.1007\/s00467-014-2803-x","journal-title":"Pediatr Nephrol"},{"key":"3077_CR19","first-page":"3807e15","volume":"27","author":"JT Kielstein","year":"2012","unstructured":"Kielstein JT, Beutel G, Fleig S, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, N\u00fcrnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry (2012) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27:3807e15","journal-title":"Nephrol Dial Transplant"},{"key":"3077_CR20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","volume":"29","author":"Y Delmas","year":"2012","unstructured":"Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, H\u00e9lou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C (2012) Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565\u2013572","journal-title":"Nephrol Dial Transplant"},{"key":"3077_CR21","unstructured":"Ekinci Z, Kenan Bek K, Aytac MB, Karadenizli A, Hancer VS. Renal outcome with eculizumab in two diarrhea-associated hemolytic ureamic syndrome cases with severe neurologic involvement. Available at www.sciencedirect.com\/science\/article\/pii\/S1561541314000234 Accessed 14 Feb 2017"},{"issue":"3","key":"3077_CR22","first-page":"246","volume":"55","author":"Z Ekinci","year":"2013","unstructured":"Ekinci Z, Candan C, Alpay H, Horstmann D, Donnerstag F, Lemke J, Hillebrand G, L\u00f6bel U, Pape L, Haffner D, Bindt C, Ahlenstiel T, Melk A, Lehnhardt A, Kemper MJ, Oh J, Hartmann H (2013) Hemolytic uremic syndrome outbreak in Turkey in 2011. Turk J Pediatr 55(3):246\u2013252","journal-title":"Turk J Pediatr"},{"issue":"4","key":"3077_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/0009922814534520","volume":"54","author":"A Saini","year":"2015","unstructured":"Saini A, Emke AR, Silva MC, Perlman SJ (2015) Response to eculizumab in Escherichia coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestations. Clin Pediatr (Phila) 54(4):387\u2013389. https:\/\/doi.org\/10.1177\/0009922814534520","journal-title":"Clin Pediatr (Phila)"},{"issue":"24","key":"3077_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001000","volume":"94","author":"L Pape","year":"2015","unstructured":"Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (2015) Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 94(24):e1000. https:\/\/doi.org\/10.1097\/MD.0000000000001000","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"3077_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/dmcn.12161","volume":"55","author":"C Gitiaux","year":"2013","unstructured":"Gitiaux C, Krug P, Grevent D, Kossorotoff M, Poncet S, Eisermann M, Oualha M, Boddaert N, Salomon R, Desguerre I (2013) Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab. Dev Med Child Neurol 55(8):758\u2013765. https:\/\/doi.org\/10.1111\/dmcn.12161","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"3077_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrneph.2012.196","volume":"8","author":"H Trachtman","year":"2012","unstructured":"Trachtman H, Austin C, Lewinski M, Stahl RA (2012) Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 8(11):658\u2013669. https:\/\/doi.org\/10.1038\/nrneph.2012.196","journal-title":"Nat Rev Nephrol"},{"key":"3077_CR27","doi-asserted-by":"publisher","unstructured":"Navarro-Garcia F (2014) Escherichia coli O104:H4 pathogenesis: an Enteroaggregative E. coli\/Shiga toxin-producing E. coli explosive cocktail of high virulence. Microbiol Spectr 2(6). https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0008-2013","DOI":"10.1128\/microbiolspec.EHEC-0008-2013"},{"issue":"5","key":"3077_CR28","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1542\/peds.2005-0785","volume":"117","author":"RS Oakes","year":"2006","unstructured":"Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117(5):1656\u20131662. https:\/\/doi.org\/10.1542\/peds.2005-0785","journal-title":"Pediatrics"},{"key":"3077_CR29","doi-asserted-by":"publisher","unstructured":"Keenswijk W, Walle JV (2017) Atypical hemolytic uremic syndrome in low resource settings: which options do we have? Ther Apher Dial. https:\/\/doi.org\/10.1111\/1744-9987.12609","DOI":"10.1111\/1744-9987.12609"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-017-3077-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-017-3077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-017-3077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T21:27:59Z","timestamp":1603574879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-017-3077-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3077"],"URL":"https:\/\/doi.org\/10.1007\/s00431-017-3077-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732381254.793565315","asserted-by":"object"}]},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}